Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

Image of text that reads "Breaking News" over myeloma cells.

FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients

April 16, 2024

cyclists on bikes

Cyclists Take On America’s Most Beautiful Bike Ride In Support Of Blood Cancer Patients

April 3, 2024

Image of text that reads "Breaking News" over leukemia cells.

FDA Approves First Targeted Treatment for Newly Diagnosed Leukemia Subtype

March 25, 2024

Image of text that reads "Breaking News" over leukemia cells.

FDA Approves First CAR T-Cell Therapy for Chronic Lymphocytic Leukemia

March 19, 2024

Image of text that reads "Breaking News" over leukemia cells.

FDA Expands Use of Leukemia Treatment to Include Children

March 18, 2024

A zoomed in image of a liquid being dropped into an object for testing

FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma

March 15, 2024

An image with text that reads Breaking News over an image of lymphoma cells.

FDA Approves First Ever BTK Inhibitor to Treat Lymphoma Subtype

March 14, 2024

Bringing Light to The Darkness of Cancer: BeiGene Named National Partner of Survivorship and Hope for The Leukemia & Lymphoma Society’s Light The Night

March 12, 2024

Text that reads "breaking news" over images of blood cancer cells.

Recent FDA Approval a ‘Great Step in the Right Direction’ for Improving Quality of Life in Blood Cancer Patients

March 11, 2024

Media Requests

For all media-related inquiries and interview requests please email mediarelations@lls.org. An LLS representative will respond as soon as possible.